myeloperoxidase inhibitors (Bristol-Myers Squibb)

N/A

Report date: 2025/01/26 17:29:51
NME

Base Information

Drug Namemyeloperoxidase inhibitors (Bristol-Myers Squibb)
Drug Alias Name7-heteroarylmethoxy-triazolopyridine analogs
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyeloperoxidase inhibitors
TargetsMyeloperoxidase
Therapy Area/IndicationsInflammationAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A